PASG
PASG clinical trials: Passage BIO, Inc.
Every trial on ClinicalTrials.gov where Passage BIO, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 3
- Trials linked
- 1
- As lead sponsor
- 2
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
PASG on the catalyst calendar · PASG registry changes
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Jun 19, 2026Actual | NCT04747431A Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 GenesPassage Bio, Inc. · Frontotemporal Dementia | PASGLead | Phase 1/Phase 2 | Terminated | Locked | Locked | Locked |
| Aug 31, 2029Sponsor estimate | NCT05368038ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening ProgramAlbert Einstein College of Medicine · Acid Sphingomyelinase Deficiency | TVTXCollaboratorAZNCollaboratorBMRNCollaboratorSNYCollaborator+4 | No phase registered | Enrolling by invitation | Locked | Locked | Locked |
| May 1, 2024Actual | NCT04041102Natural History Study of Infantile and Juvenile GM1 Gangliosidosis (GM1) PatientsUniversity of Pennsylvania · GM1 Gangliosidosis | PASGCollaborator | No phase registered | Completed | Locked | Locked | Locked |
- Primary completion Jun 19, 2026ActualPhase 1/Phase 2NCT04747431A Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 GenesPassage Bio, Inc. · Frontotemporal DementiaTerminatedPASGLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 31, 2029Sponsor estimateNo phase registeredNCT05368038ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening ProgramAlbert Einstein College of Medicine · Acid Sphingomyelinase DeficiencyEnrolling by invitationTVTXCollaboratorAZNCollaboratorBMRNCollaboratorSNYCollaborator+4
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 1, 2024ActualNo phase registeredNCT04041102Natural History Study of Infantile and Juvenile GM1 Gangliosidosis (GM1) PatientsUniversity of Pennsylvania · GM1 GangliosidosisCompletedPASGCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 3 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner